Human Health Innovation

"Creating value through innovation" is Boehringer Ingelheim's motto. As a research-based pharmaceutical company, our goal is to help patients achieve a longer life and a better quality of life - the most valuable thing about a disease - by developing new innovative therapies. Based on this motivation, we focus our research on disease areas with a high unmet medical need in order to provide therapeutic assistance to those who need it most.

Human health innovation
Boehringer Ingelheim: Arbeiten mit Sinn

With a pipeline of around 100 clinical and pre-clinical projects, and the potential to deliver up to 15 new medicine approvals by 2025, we continue our track record of long-term innovation-led performance.